Search Results - "Innocent M. Ali"

Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodology by Mousa, Andria, Cuomo-Dannenburg, Gina, Thompson, Hayley A, Chico, R Matthew, Beshir, Khalid B, Sutherland, Colin J, Schellenberg, David, Gosling, Roly, Alifrangis, Michael, Hocke, Emma Filtenborg, Hansson, Helle, Chopo-Pizarro, Ana, Mbacham, Wilfred F, Ali, Innocent M, Chaponda, Mike, Roper, Cally, Okell, Lucy C

“…Recently revised WHO guidelines on malaria chemoprevention have opened the door to more tailored implementation. Countries face choices on whether to replace…”
Get full text

Arboviruses as an unappreciated cause of non-malarial acute febrile illness in the Dschang Health District of western Cameroon by Ali, Innocent M, Tchuenkam, Valery P. K, Colton, Mia, Stittleburg, Victoria, Mitchell, Cedar, Gaither, Claudia, Thwai, Kyaw, Espinoza, Daniel O, Zhu, Yerun, Jamal, Haaris, Key, Autum, Juliano, Jonathan J, Christopher, Tume B, Piantadosi, Anne, Waggoner, Jesse J, Collins, Matthew H

“…Acute febrile illness is a common problem managed by clinicians and health systems globally, particularly in the Tropics. In many regions, malaria is a leading…”
Get full text

Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis (1998-2020) by Niba, Peter Thelma Ngwa, Nji, Akindeh M, Evehe, Marie-Solange, Ali, Innocent M, Netongo, Palmer Masumbe, Ngwafor, Randolph, Moyeh, Marcel N, Ngum, Lesley Ngum, Ndum, Oliva Ebie, Acho, Fon Abongwa, Mbu'u, Cyrille Mbanwi, Fosah, Dorothy A, Atogho-Tiedeu, Barbara, Achonduh-Atijegbe, Olivia, Djokam-Dadjeu, Rosine, Chedjou, Jean Paul Kengne, Bigoga, Jude D, Moukoko, Carole Else Eboumbou, Ajua, Anthony, Achidi, Eric, Tallah, Esther, Leke, Rose G F, Tourgordi, Alexis, Ringwald, Pascal, Alifrangis, Michael, Mbacham, Wilfred F

“…Malaria remains highly endemic in Cameroon. The rapid emergence and spread of drug resistance was responsible for the change from monotherapies to…”
Get full text

Discrete Survival Model Analysis of Plasmodium falciparum Response to Artemisinin-Based Combination Therapies among Children in Regions of Varying Malaria Transmission in Cameroon by Nji, Akindeh M., Ali, Innocent M., Niba, Peter Thelma Ngwa, Marie-Solange, Evehe, Heumann, Christian, Froeschl, Guenter, Mbacham, Wilfred F.

“…The need to monitor changes in parasite clearance following treatment with artemisinin-based combination therapies (ACTs) is important in the containment of…”
Get full text

Comparison of the Accuracy of Four Malaria Diagnostic Methods in a High Transmission Setting in Coastal Cameroon by Mbacham, Wilfred F., Ghogomu, Stephen M., Evehe, Marie S., Netongo, Palmer M., Nji, Akindeh M., Njimoh, Dieudonné Lemuh, Ali, Innocent M., Moyeh, Marcel N., Atogho-Tiedeu, Barbara

“…Background. Despite recommendation from the World Health Organization that all malaria suspected patients undergo a parasitological confirmation using rapid…”
Get full text

Study To Evaluate the Performance of a Point-of-Care Whole-Blood HIV Viral Load Test (SAMBA II HIV-1 Semi-Q Whole Blood) by Brook, Gary, Stepchenkova, Tetiana, Ali, Innocent M, Chipuka, Sandra, Goel, Neha, Lee, Helen

“…Remote areas of many low and middle income (LMI) countries have poor access to HIV viral load (HIV VL) testing. The SAMBA II (simple amplification-based assay)…”
Get full text

Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes by Netongo, Palmer M., Ngongang, Eric-Olivier, Ali, Innocent M., Mbacham, Wilfred F., Achidi, Eric A., Ajua, Anthony, Atogho-Tiedeu, Barbara

“…Background. In Cameroon, both Artesunate-amodiaquine (AS/AQ) and artemether-lumefantrine (AL) are used as first-line treatment against uncomplicated malaria in…”
Get full text

Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children by Nji, Akindeh M, Ali, Innocent M, Moyeh, Marcel N, Ngongang, Eric-Oliver, Ekollo, Aristide M, Chedjou, Jean-Paul, Ndikum, Valentine N, Evehe, Marie S, Froeschl, Guenter, Heumann, Christian, Mansmann, Ulrich, Ogundahunsi, Olumide, Mbacham, Wilfred F

“…Artemether-lumefantrine and artesunate-amodiaquine are first-line treatment for uncomplicated malaria in Cameroon. No study has yet compared the efficacy of…”
Get full text

Field evaluation of the 22 rapid diagnostic tests for community management of malaria with artemisinin combination therapy in Cameroon by Ali, Innocent M, Bigoga, Jude D, Forsah, Dorothy A, Cho-Ngwa, Fidelis, Tchinda, Vivian, Moor, Vicky Ama, Fogako, Josephine, Nyongalema, Philomena, Nkoa, Theresa, Same-Ekobo, Albert, Mbede, Joseph, Fondjo, Etienne, Mbacham, Wilfred F, Leke, Rose G F

“…All suspected cases of malaria should receive a diagnostic test prior to treatment with artemisinin-based combinations based on the new WHO malaria treatment…”
Get full text

Predominance of N-acetyl transferase 2 slow acetylator alleles in children less than ten years experiencing adverse treatment events following artemisinin-based combination therapy in North and South West Regions of Cameroon by Jean, P C Kengne, Akindeh, M Nji, Innocent, M Ali, Olivia, Ekollo, M Aristid, Wilfred, F Mbacham

“…The human N-acetyltransferase II (NAT2) gene may vary between individuals resulting in variability in the incidence of adverse drug reactions. We set out in…”
Get full text

Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon by Moyeh, Marcel N., Njimoh, Dieudonne L., Evehe, Marie Solange, Ali, Innocent M., Nji, Akindeh M., Nkafu, Dominique N., Masumbe, Palmer N., Barbara, Atogho-Tiedeu, Ndikum, Valentine N., Mbacham, Wilfred F.

“…Background. As a result of the spread of parasites resistant to antimalarial drugs, Malaria treatment guidelines in Cameroon evolved from nonartemisinin…”
Get full text

Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodology by Andria Mousa, Gina Cuomo-Dannenburg, Hayley A. Thompson, R. Matthew Chico, Khalid B. Beshir, Colin J. Sutherland, David Schellenberg, Roly Gosling, Michael Alifrangis, Emma Filtenborg Hocke, Helle Hansson, Ana Chopo-Pizarro, Wilfred F. Mbacham, Innocent M. Ali, Mike Chaponda, Cally Roper, Lucy C. Okell

Get full text

Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine–pyrimethamine five years (2016–2020) after the implementation of seasonal malaria chemoprevention in Cameroon by Tchuenkam, Pacome V. K., Ngum, Lesley N., Ali, Innocent M., Chedjou, Jean Paul K., Nji, Akindeh M., Netongo, Palmer M., Ngwafor, Randolph, Niba, Peter Thelma N., Tah, Calvino F., Nana, William D., Ekoyol, Germaine, Bigoga, Jude D., Ashu, Dorothy F., Tume, Christopher B., Mbacham, Wilfried F.

“…Background Antimalarial drug resistance is a major challenge in the fight against malaria. Cameroon implemented seasonal malaria chemoprevention (SMC) with…”
Get full text